Delivery Order SPE2DR25D2005-SPE2DR26FE8S9
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,044.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. Issued on December 8, 2025, with an ultimate completion date of December 9, 2025, this firm fixed-price delivery order represents a small-value transaction within the federal medical supply procurement process. The award was made without a set-aside designation, indicating competitive selection among qualified vendors. AmerisourceBergen...
- The Defense Logistics Agency awarded a $14,484.65 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed-price, competitive award with no set-aside designation, with an ultimate completion date of November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, one day after the award date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.18 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.70 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram unit. The contract, which was competitively awarded with no set-aside designation, carries a completion date of December 15, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,435.28 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-competitive delivery order, issued on December 12, 2025, represents a firm fixed-price purchase with an ultimate completion date of December 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,493.20 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This order, issued on August 13, 2025, with completion targeted for August 14, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam (10 grams) with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on September 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,335.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. The award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. This delivery order represents a non-set-aside, competitively awarded transaction and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8S9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,097.80 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam 10GM, a pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of December 15, 2025, and was awarded on December 12, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contracting history demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains for the DLA's Medical Supply Chain and affiliated government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/11/25 |